Raw-Material Authentication Using a Handheld Raman Spectrometer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Raw-Material Authentication Using a Handheld Raman Spectrometer
Using a handheld Raman spectrometer, the authors developed methods for 28 commonly used excipients and active ingredients.


Pharmaceutical Technology
Volume 3, Issue 32

5. J.A. Ryan et al., "Rapid Verification of Identity and Content of Drug Formulations Using Mid-Infrared Spectroscopy," J. Pharm. Biomed. Anal. 9 (4), 303–310 (1991).

6. For example, United States Pharmacopeia-National Formulary and European Pharmacopeia.

7. T. Vankeirsbilck et al., "Applications of Raman Spectroscopy in Pharmaceutical Analysis," TrAC 21 (12), 869–877 (2002).

8. R.L. McCreery et al., "Noninvasive Identification of Materials Inside USP Vials with Raman Spectroscopy and a Raman Spectral Library," J. Pharm. Sci. 87 (1), 1–8 (1998).

9. R. Cantu et al., "A Simple Approach for Developing, Validating, and Transferring an Identification Method for Multidose Pharmaceutical Products using FT-Raman Spectroscopy," Am. Pharm. Review 10 (2), pp. 96–103, 111 (Jan.–Feb. 2007).

10. D.A.C. Compton and S.V. Compton "Examination of Packaged Consumer Goods by Using FT-Raman Spectrometry," Applied Spec. 45 (10), 1587–1589 (1991).

11. S.G.Skoulika and C.A.Geurgio, "Rapid, Noninvasive Quantitative Determination of Acyclovir in Pharmaceutical Solid Dosage Forms Through their Poly(vinyl chloride) Blister Package by Solid-State Fourier Transform Raman Spectroscopy," Applied Spec. 57 (4), 407–412 (2003).

12. R.L. McCreery, "Introduction and Scope," in Raman Spectroscopy for Chemical Analysis (John Wiley & Sons, New York, United States, 2000), pp. 1–14.

13. European Medicines Agency (EMEA), Note for Guidance on the Use of Near Infrared Spectroscopy by the Pharmaceutical Industry and the Data Requirements for New Submissions and Variations (London, UK, 2003).

14. C.T. John and N.C. Pixley "Methodology for NIR Identification of Pharmaceutical Finished Products with Emphasis on Negative Controls and Data Driven Threshold Value Selection," Am. Pharm. Review, 10 (2), 120–124 (Jan–Feb 2007).

15. FDA, Center for Drug Evaluation and Research, Guidance for Industry: Testing of Glycerin for Diethylene Glycol (Rockville, MD, 2007).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here